Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:32 pm Purchase | 2023-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | David D. Chang, M.D., Ph.D. | 9,964,347 5.800% | 1,536,715 (+18.23%) | Filing History |
| 2024-02-13 4:59 pm Purchase | 2023-12-29 | 13G | Allogene Therapeutics, Inc. ALLO | The Vanguard Group | 9,030,825 5.370% | 1,765,604 (+24.30%) | Filing History |
| 2024-02-09 08:35 am Purchase | 2024-02-08 | 13G | Allogene Therapeutics, Inc. ALLO | FMR LLC | 25,241,499 14.999% | 323,544 (+1.30%) | Filing History |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | BlackRock Inc. BLK | 10,001,804 5.900% | 1,115,232 (+12.55%) | Filing History |
| 2024-01-23 10:02 am Sale | 2023-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | STATE STREET CORP STT | 2,427,284 1.440% | -6,739,124 (-73.52%) | Filing History |
| 2023-10-25 5:29 pm Unchanged | 2023-08-02 | 13D | Allogene Therapeutics, Inc. ALLO | PFIZER INC PFE | 22,032,040 13.140% | 0 (Unchanged) | Filing History |
| 2023-07-10 10:20 am Purchase | 2023-07-07 | 13G | Allogene Therapeutics, Inc. ALLO | FMR LLC | 24,917,955 17.085% | 24,917,955 (New Position) | Filing History |
| 2023-02-13 4:33 pm Purchase | 2022-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | David D. Chang, M.D., Ph.D. | 8,427,632 5.700% | 8,427,632 (New Position) | Filing History |
| 2023-02-13 4:31 pm Purchase | 2022-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | Arie Belldegrun, M.D. | 8,858,861 6.100% | 1,655,613 (+22.98%) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Allogene Therapeutics, Inc. ALLO | The Vanguard Group | 7,265,221 5.040% | 7,265,221 (New Position) | Filing History |
| 2023-02-03 3:52 pm Purchase | 2022-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | STATE STREET CORP STT | 9,166,408 6.360% | 9,166,408 (New Position) | Filing History |
| 2023-02-03 12:09 pm Purchase | 2022-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | BlackRock Inc. BLK | 8,886,572 6.200% | 8,886,572 (New Position) | Filing History |
| 2022-04-07 4:11 pm Unchanged | 2022-03-31 | 13D | Allogene Therapeutics, Inc. ALLO | PFIZER INC PFE | 22,032,040 15.400% | 0 (Unchanged) | Filing History |
| 2022-02-14 5:20 pm Sale | 2021-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | Seaview Trust | 7,041,120 4.940% | -299,747 (-4.08%) | Filing History |
| 2022-02-14 3:36 pm Purchase | 2021-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | Arie Belldegrun, M.D. | 7,203,248 5.000% | 708,755 (+10.91%) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Allogene Therapeutics, Inc. ALLO | Capital Research Global Investors | 0 0.000% | -12,640,338 (Position Closed) | Filing History |
| 2022-02-11 11:19 am Sale | 2022-02-14 | 13G | Allogene Therapeutics, Inc. ALLO | Capital International Investors | 1,728,252 1.200% | -5,971,451 (-77.55%) | Filing History |
| 2022-02-10 4:51 pm Sale | 2021-04-20 | 13G | Allogene Therapeutics, Inc. ALLO | GILEAD SCIENCES INC. GILD | 1,156,689 0.800% | -6,330,000 (-84.55%) | Filing History |
| 2022-01-18 4:50 pm Purchase | 2022-01-12 | 13D | Allogene Therapeutics, Inc. ALLO | TPG GP A, LLC | 18,716,306 13.200% | 18,716,306 (New Position) | Filing History |
| 2021-09-17 4:17 pm Unchanged | 2021-09-10 | 13D | Allogene Therapeutics, Inc. ALLO | PFIZER INC PFE | 22,032,040 15.500% | 0 (Unchanged) | Filing History |